Mode
Text Size
Log in / Sign up

FNA-Tg and BRAF V600E analysis can rectify histopathological misdiagnosis of cervical lymph node metastasisCombined Testing Corrects Diagnosis of Thyroid Cancer Lymph Node Spread

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that combined FNA-Tg and BRAF V600E analysis may improve diagnosis of cervical lymph node metastasis in PTC.

This case report describes the clinical management of a 52-year-old female farmer diagnosed with papillary thyroid carcinoma. The report focuses on the utility of combining FNA-Tg and BRAF V600E analysis to improve diagnostic accuracy in cervical lymph node metastasis.

The primary finding was that this combined testing approach rectified a histopathological misdiagnosis of cervical lymph node metastasis, confirming micrometastasis upon re-evaluation. This suggests that molecular and protein markers may provide necessary clarity when standard pathology is inconclusive.

A major limitation of this evidence is the single case report format, which precludes generalizability to broader populations. The clinical relevance lies in the potential for these tests to inform management strategies for cervical lymph node metastases from papillary thyroid carcinoma.

Clinicians should interpret these results with caution due to the low certainty associated with a single-case study. While the finding is clinically relevant for diagnostic accuracy, it does not establish a standard of care.

How this fits prior evidence

This case report addresses a gap in diagnostic precision for papillary thyroid carcinoma. It complements existing evidence regarding predictive tools, such as the machine learning model that predicts central lymph node metastasis and the nomogram model using NLR, age, and ultrasound features to differentiate papillary thyroid carcinoma from benign nodules.

This report describes a single case involving a 52-year-old female farmer diagnosed with papillary thyroid carcinoma. The study looked at how combining two specific tests, FNA-Tg and BRAF V600E analysis, could help identify if cancer had spread to the lymph nodes in the neck.

The results showed that this combined testing method corrected a previous mistake in the initial diagnosis. While the first check missed it, the re-evaluation confirmed the presence of micrometastasis in the cervical lymph node. This suggests that using both tests together can provide a more accurate picture for doctors.

Because this is a single case report, the evidence is limited and cannot be used to make broad claims about all patients. However, it highlights a potential strategy for managing thyroid cancer cases where clear diagnosis of lymph node involvement is necessary. Patients should discuss these specific testing options with their oncology team.

What this means for you:
Combining FNA-Tg and BRAF V600E analysis may help doctors more accurately detect cancer spread in thyroid patients.

Common questions

What was found in this specific case?

In a single case involving a 52-year-old female with papillary thyroid carcinoma, combining FNA-Tg and BRAF V600E analysis corrected a previous misdiagnosis. The re-evaluation confirmed the presence of micrometastasis in a cervical lymph node that was not initially identified.

How does this testing help patients with thyroid cancer?

The combination of FNA-Tg and BRAF V600E analysis may offer a more accurate way to identify if cancer has spread to the neck. This can help doctors better manage the clinical treatment for patients with papillary thyroid carcinoma.

Is this finding enough to change standard medical practice?

Because this is a single case report, the evidence is limited and not yet enough to change standard practices. It serves as an early look at a potential strategy for managing cervical lymph node metastases in thyroid cancer.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
This study reports a rare case in which the integration of Thyroglobulin measurement in the needle washout after fine-needle aspiration (FNA-Tg) and BRAF V600E analysis rectified a histopathological misdiagnosis of cervical lymph node metastasis originating from papillary thyroid carcinoma. The patient was a 52-year-old female farmer who presented with a diagnosis of papillary thyroid carcinoma. Histopathological assessment of cervical lymph nodes returned negative findings, whereas both FNA-Tg and BRAF V600E are positive results. Following a comprehensive re-evaluation of the histopathological specimens, a definitive diagnosis of a rare case of cervical lymph node micrometastasis was confirmed. This case report provides a systematic review of the current literature and critically examines the diagnostic utility of combining FNA-Tg with BRAF V600E in the detection of cervical lymph node metastases from PTC, potentially offering a therapeutic strategy for the clinical management of such conditions.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.